Asymmetrical atrophy of thalamic subnuclei in Alzheimer's disease and amyloid-positive mild cognitive impairment is associated with key clinical features. (2019)
Attributed to:
Innovative Technologies for Stratified and Experimental Medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.dadm.2019.08.001
PubMed Identifier: 31667328
Publication URI: http://europepmc.org/abstract/MED/31667328
Type: Journal Article/Review
Volume: 11
Parent Publication: Alzheimer's & dementia (Amsterdam, Netherlands)
ISSN: 2352-8729